(Q73132167)
Statements
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31 (English)
M V Pilepich
R Caplan
R W Byhardt
C A Lawton
M J Gallagher
J B Mesic
G E Hanks
C T Coughlin
A Porter
W U Shipley